Asia-Pacific Americas Africa Europe Middle East

NEULAND LABORATORIES LIMITED

Company Profile:

NEULAND LABORATORIES LIMITED

It is a factory/manufacturer.

Neuland Laboratories Limited is an Indian pharmaceutical manufacturer specializing in the development and production of Active Pharmaceutical Ingredients (APIs), advanced intermediates, and contract manufacturing services for the global pharmaceutical industry. Established in 1984, the company is recognized for its strong emphasis on research and development, quality systems, and regulatory compliance. Neuland operates multiple manufacturing facilities and serves customers worldwide, offering a diverse portfolio of therapeutic APIs.

Enterprise Products

Neuland Laboratories Limited manufactures and sells Active Pharmaceutical Ingredients (APIs) and provides Custom Manufacturing Solutions (CMS).

Their key Active Pharmaceutical Ingredients (APIs) include:

Donepezil Hydrochloride

Levetiracetam

Moxifloxacin Hydrochloride

Olanzapine

Rivastigmine Tartrate

Sertraline Hydrochloride

Sumatriptan Succinate

Tamsulosin Hydrochloride

Ziprasidone Hydrochloride

Carbidopa

Benserazide Hydrochloride

Ropinirole Hydrochloride

Pramipexole Dihydrochloride

Rizatriptan Benzoate

Telmisartan

Valsartan

Ezetimibe

Rosuvastatin Calcium

Fenofibrate

Amlodipine Besylate

Dapagliflozin

Empagliflozin

Canagliflozin

Vildagliptin

Sitagliptin Phosphate Monohydrate

Rifaximin

Prucalopride Succinate

Linaclotide

Adapalene

Isotretinoin

Finasteride

Dutasteride

Tadalafil

Sildenafil Citrate

Pregabalin

Gabapentin

Lamotrigine

Topiramate

Everolimus

Sirolimus

Tacrolimus

Mycophenolate Mofetil

Business Registration Information:

Manager:

Dr. D. R. Rao (Chairman & Managing Director)

Phone:

+91-40-30211600

E-mail:

investors@neulandlabs.com

Official Website:
Address:

Neuland Laboratories Ltd 8-2-332/8, Road No. 3, Banjara Hills Hyderabad – 500 034, Telangana, India

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.